DRAFT DRAFT DRAFT
MEETING OF THE RBM PARTNERSHIP
Monitoring and Evaluation Reference Group (MERG)
Household Survey Task Force for Malaria
5-6 January 2005 – Arlington, VA, USA
JSI Training and Research
1616 N. Fort Myers Dr.
I. Welcome and Introductions
Bernard Nahlen, RBM/WHO
Tessa Wardlaw, UNICEF
Erin Eckert, MEASURE Evaluation
Nahlen, Wardlaw and Eckert welcomed everyone to the meeting. The RBM Monitoring and Evaluation
Reference Group (MERG) Survey Task Force meeting was called to discuss and finalize outstanding
issues since the last MERG and Survey Task Force meetings. The objectives of the meeting were to:
1. Finalize the MIS household survey package, including the survey questionnaire, the survey
indicator description manual and supporting documents and tools.
2. Develop a plan for dissemination of the MIS package and implementation of the first MIS in the
3. Review progress on the other survey activities including MICS, facility surveys, etc.
The meeting began with updates on the progress of comparing and harmonizing the Demographic and
Health Surveys (DHS) and UNICEF’s Multi-Indicator Cluster Surveys (MICS) in 2005/6. 1, 2
II. Update on the Progress/issues with DHS and MICS for 2005/6 (Objective 3)
Fred Arnold, ORC Macro/DHS
Tessa Wardlaw, UNICEF
Pat David, JSI
Demographic and Health Survey (DHS) Update
Arnold began by updating the group on the DHS and changes that have been made to the questionnaire.
Every five years with the renewal of the DHS contract, the survey is reviewed with the funder of the
DHS, the United States Agency for International Development (USAID) and other survey experts.3 The
final questions for this five year review have been submitted and changed and the revised questionnaire
will be final in the next two weeks. This revision is already being used in the field and the tabulation plan
and manuals that correspond with the questionnaire have begun to be revised as well.
Fred Arnold noted the major changes to the DHS questionnaire:
• On select material related TB and Stigma and Discrimination of TB
• Items that make up the wealth index (40 additional items)
• Expansion of the child nutrition information questions
• New women’s nutrition questions
• New focus on post natal care for children
ORC Macro/DHS and DHS surveys, please visit: http://www.measuredhs.com/ and http://www.orcmacro.com/
For UNICEF/MICS information, please visit: http://www.unicef.org/statistics/index_24302.html
For more information on USAID, visit: http://www.usaid.gov/
DRAFT DRAFT DRAFT
• Expansion of HIV/AIDS questions, including male circumcision questions (there is also a module
on circumcision that includes 15 questions).
• New questions on birth registration.
• Child cough, diarrhea and treatment questions were harmonized with MICS
o Also asked about runny/blocked nose
o For diarrhea, added Zinc as a treatment option and a follow up question asking how long
it was administered.
Also revised were questions on all three childhood diseases: fever, acute respiratory illness (ARI)/cough
and diarrhea—the new questions ask what treatment the child was given and similar questions are asked
about food that was given. There is also a new focus on home-based treatment (“was medication first
given at home or where did the medication come from?”):
• At what point after the fever started did treatment begin?
• For Intermittent Preventive Treatment (IPT), the dose for sulfadoxine-pyrimethamine (SP) is
• A response category was added for an antibiotic that was given, but the name/brand/type can not
be specified or remembered.
The DHS Malaria Module has also been revised and updated and USAID has suggested that if any
changes to this questionnaire are made in high malaria prevalence countries, a justification needs to be
sent to USAID Washington. The reason is that USAID wants to ensure that there is standardization
among partners and that indicators will be comparable across countries.
The DHS AIDS Indicator Survey (AIS) also includes bednet questions—the Uganda AIS is currently in
the field and includes the question: “Does the household have any bednets?” Most of the AIS surveys
that are implemented in the US Emergency Plan for AIDS Relief countries will be asking malaria
questions.4 These surveys are done about every two and a half years (either a DHS or AIS, because the
AIS is automatically a module in the DHS) and they often include HIV testing; although Guyana does not
include HIV testing because they do not have the laboratory capacity to perform the tests.
Arnold also reminded the group that John Miller has put together the survey schedule list which can be
found on the RBM website: http://rbm.who.int/merg to ensure that a DHS and MICS do not overlap in
same year, in any country—this coordination is important so countries are not overwhelmed with data
UNICEF, Multiple Indicator Cluster Survey (MICS) Update
Since November 2004 many changes have been made to the MICS questionnaire which Pat David and
Tessa Wardlaw reviewed with the group. Most of the questionnaire is finalized and the pre-testing will
begin in February 2005 in Guyana and the first training workshop is planned for April 2005. It has not
yet been decided where the first technical workshop will be held. Currently, about 40 countries are
planning to do a MICS.
In December 2004, Pat David and the MICS team reviewed the draft questionnaire from November 2004
to reduce the size of the questionnaire—David reported that the task has been difficult and quite a bit has
been done to make the questionnaire shorter and more manageable. The MICS is more than 15% larger
than the last round and the MICS review team has taken apart the malaria modules and set them aside
from the core questions to use in malaria affected countries. RBM has provided country lists to the
For more information on the US Emergency Plan for AIDS Relief, visit:
http://www.state.gov/s/gac/rl/or/c11652.htm and for information on the AIS, please visit: www.measuredhs.com
DRAFT DRAFT DRAFT
UNICEF/MICS team to make sure that the correct modules are used in Malaria affected countries. RBM
has also agreed to work with the MICS teams to give support in identifying local bednet and medication
brand names. One of the major changes in the MICS is in the bednet roster. The reasons for the major
changes to the net roster are listed below:
• The extent and size of the household survey limits UNICEF’s ability to use the net inventory
because there are additional sections that take up a considerable amount of time during the
interview which need to remain in the MICS (i.e. performing iodine tests on salt, child labor
o there will be a simpler series of questions on net inventory which are not exactly
comparable, but will provide a decent indicator for household Insecticide Treated Nets
• MICS will not measure the percent of pregnant women who slept under a bednet, but will still
measure children under five who slept under a net.
Pat David then walked through each of the ITN questions included in the MICS and explained that
interviewers will be instructed to probe for the ITN brand and to verify and observe the net, if possible (to
decrease some of the “don’t know” category, without leading the respondent towards a specific response).
The group reviewed the MICS questionnaires that Pat David presented and focused on the MICS ITN
module questions and the Malaria module for children under five questions.
MICS ITN Module
It was decided in the ITN module that probing, verifying and observing are important for interviewers so
as to receive the most reliable information. It was suggested and agreed that some of the questions be
reordered for better flow and a few of the questions with “no” and “don’t know” responses will be
removed for clarity. Unfortunately, the bednet questions prove to be difficult for interviewers and
respondents due to deciphering which nets were soaked, when they were soaked, which nets are pre-
treated, when and which nets have been washed. It was mentioned that to alleviate some of these
problems, MICS could consider using the format of the MIS, which asks how long ago the net was
purchased. As an additional response, Rick Steketee from Centers for Disease Control and Prevention
(CDC) explained that there is a device that can detect bromine on nets (which is one of the chemicals
used in treating bednets). However, bromine isn’t the only chemical used in treating mosquito nets and
the device is quite expensive. Pat David concluded by explaining even in eliminating the net roster from
the MICS, the global indicator of “households with at least one treated net” is still able to be measured
with the survey.
Additionally, the timeframe for treating an ITN is not standard within the MICS and DHS. Fred Arnold
confirmed that the final version of DHS and the MIS guidelines include a timeframe of 12 months and
that the interviewer should add a probe to verify the date. This is the same process for other
date/timeframe issues in the questionnaires, such as with infant mortality. The MICS will include 0-
11.9999 months and then probe to verify which month to be sure it is correct.
It was also suggested that as part of the Guyana Malaria Control Program testing of MICS, that UNICEF
might want to take some of these question that have raised discussion/concern and pilot test them for
feedback to MICS.
MICS Malaria Module for Under-Fives
A difference highlighted between the MIS and the MICS in this module was related to children with fever
and where treatment was first administered. It was decided that the question in the MICS “Was (name)
seen at a health facility during this illness?” should be changed to “Did you seek advice or treatment for
the illness outside the home?” and followed by a ‘where’ question so as to provide more information
regarding from where treatment came. Bernhard Nahlen also mentioned that in most cases, less than half
DRAFT DRAFT DRAFT
of respondents go to a public health facility for treatment, but the information will be useful because the
HMIS will not report on treatment seeking.
Pat David mentioned that some of the questions in the MICS Malaria Under-Fives module use the same
questions as the MIS, however the skip patterns are different. Fred Arnold and Pat David agreed that the
surveys will be changed to be consistent. The DHS and MICS bednet questions will also be harmonized
and DHS will drop the skip patterns in their household survey and in the MIS. The MICS will drop
“don’t know” responses for permanent bednet, pretreated bednet and other bednet, but leave one “don’t
know” response in the question. UNICEF will also train interviewers not to probe using the terms
“permanent” or “pretreated” to avoid additional bias.
MICS Maternal and Newborn Health Module
Intermittent Preventive Treatment (IPT)
It was pointed out that the MICS asks questions in this module to women with a live birth in the two years
preceding the date of the interview, however, in the MIS similar questions are asked for women who have
given birth to a live child in the last five years. Fred Arnold explained that the problem with changing the
timeframe in the MIS to two years is that the MIS might not have a large enough sample size to provide
robust figures. It was decided to harmonize the timeframe for a woman’s last birth to “last pregnancy with
a live birth within the last two years” and note the sample size issue. This indicator definition will also be
change in the “Guidelines for Core Population Coverage Indicators for Roll Back Malaria”. 5
This module also includes Chloroquine in the response category to the MICS question: “Which medicines
do you take to prevent malaria (MN6B)”. Bernard Nahlen explained that SP is really the only medication
that is recommended for use as IPT until further research is available. It was decided that Chloroquine
should be left in the response category and artemisin-based combination therapy (ACT) and other local
malaria medication should be added.
Bernard Nahlen also mentioned a new finding related to IPT that could have an impact on household
surveys. Evaluations in Nigeria and Uganda looked at IPT questions and responses through Antenatal
Clinic (ANC) records which showed that responses to IPT questions might be more reliable from ANC,
than through household surveys—this might be especially true in places where ANC coverage is good,
however in places like Ethiopia, with 35% ANC coverage, another mechanism might be needed to get
correct information. Nahlen cautioned though that household survey IPT questions should not be
replaced with ANC data yet, because more research needs to be done to compare the two types of data.
Lastly, a reminder for MICS and MIS training and field work: interviewers should have a picture and/or a
packet of labels to use for probing and verifying bednet brands and common medication—the local
malaria program should help with this in areas where it is relevant and this will also help countries
become involved and encourage the survey process to be a joint effort with the country program.
During a break, Pat David reworked the MICS questionnaire and redistributed it for a final review by the
group. David will return to UNICEF to review and verify the changes with the MICS team and let the
RBM Household Survey Task Force know the final decisions.6
III. Finalization of the MIS (Objective 1)
Fred Arnold, ORC Macro/DHS
RBM, MEASURE Evaluation, WHO, UNICEF. (July 2004). Guidelines for Core Population Coverage Indicators
for Roll Back Malaria: To be obtained from Household Surveys. MEASURE Evaluation: Calverton, Maryland.
To view the MICS questionnaire, please visit: http://www.unicef.org/statistics/index_24302.html
DRAFT DRAFT DRAFT
Arnold reviewed each piece of the MIS with the group and brought up issues that needed to be resolved to
finalize the package. He reminded the group that there has not been a technical review yet, but a plan for
a final review needs to be agreed upon during this meeting.
Arnold introduced each piece of the MIS package (as of 5 January 2005), below.
Guidelines for Core Population Indicators for Roll Back Malaria: to be obtained from household
Household and Women’s Questionnaire
Selected data tabulation plan
Sampling Manual—not written by a sampling expert, needs further review
Household Listing Manual
Anemia Testing Manual—current manual is five years old and will be updated shortly.
Parasite Testing Manual—only have a 2001 document, it needs to be reviewed/updated
Specific Issues with the MIS Questionnaire7
Fred Arnold presented a specific list of questions which was discussed to remedy any final
inconsistencies with the MICS and to ensure full comparability. Comment [M1]: I listed the
Household questionnaire: specific questions/issues and
responses, however, I can collapse
• Question (Q) 20: Are terms “permanent net” and “pretreated net” correct? these into a paragraph if you
Leave both as is. The footnotes in the MIS disappear in the final version—the survey director prefer.
and designers will use this information to decide what category brand names go into the questionnaire.
The interviewers will only see the brand names.
• Q19 and 23: Previously, “months ago” was changed to three years for both of these questions, but
MICS and DHS have agreed on a two-year cutoff for Q. 23. Should the three-year cutoff in Q. 19 be
changed as well?
Keep MICS the same and the MIS as is.
• Q25: Can one person sleep under more than one net?
It is important that the child slept under a net and if one night s/he slept under an ITN and
another night did not, record the best response (i.e. ITN better than pretreated etc.).
• Q32-33: When asking for consent change “responsible adult” to “adult responsible for child”?
Must be a parent or someone responsible for that child, not any adult. Fred suggested that if a
parent is around but gone 1-2 hours the interviewer should wait until the parent returns unless they are
The MIS Questionnaire will be located in the future at: http://rbm.who.int/merg
DRAFT DRAFT DRAFT
gone for days, then that adult who is in charge of the child while the parent is out can decide. Leave the
question as an adult who is responsible for the child—the manual will explain this further as well.
• Q35: In the DHS, the cutoff for referral due to severe anemia is 7g/dl for children. RBM suggests a
cutoff of 8g/dl as a definition of severe anemia related to malaria. Is there a need for consistency?
Leave MIS as 7g/dl. RBM uses a cut off of 8g/dl or less because it is considered more
severe/dangerous to have a child with low hemoglobin and high parasitemia and there is a need to detect
this trend in a child quickly.
• Addition of indoor residual spraying question(s) (IRS) or a placeholder for those questions?
Put place holder for IRS before Q15 and call it Q15a, b etc. There are no standard set of
questions for IRS agreed on by RBM, but various countries have added questions on the DHS about IRS
as needed. 8 Some country programs do not have their own monitoring system and have asked for
questions to be included in surveys. These questions should be asked only where IRS is a major form of
malaria control and they should be tested (i.e. possible confusion between spray products, such as
“Doom” that can be bought by anyone in a market vs. community or household spraying by a designated
• Q309: If woman was given a prescription for SP during an antenatal visit, but got the medicine
elsewhere, is that considered to be “during an antenatal visit?”
If the drug was obtained during an antenatal visit only should count in the indicator.
• Q318: Add Artemisin-based Combination Therapy (ACT) in the response categories?
Add ACT to the list and specify additional local drugs for each country. The rationale document
for the MIS should also explain that visuals will be needed to show what different drugs look like in
addition to the local brand/names.
• Inclusion of Global Positioning System (GPS) coordinates at the cluster level?
A Recommendation will be included in the manual to have community level GPS and then include
guidance on issues to consider and steps to take if household level GPS is requested. Rick Steketee will
provide CDC considerations on household level geo-positioning to Fred Arnold/DHS. Many agreed that
using GPS would be very helpful and beneficial. However, there are ethical considerations in using GPS
at the household level, to ensure that surveys can not be linked with actual household locations—an error
can be introduced to ensure this does not happen. However, community level GPS is the best and easiest
way to provide the information. Fred Arnold will also make reference to the CDC, DHS and WHO
materials on GPS and household surveys.
MIS Tabulation Plan
The group discussed the changes to the tabulation plan and that Table 4 will be changed to include: any
dose of anti-malarial drugs, one dose, two or more doses (with at least one of the doses from ANC), more
than two doses, one dose from an ANC, and two doses from an ANC. Column three should have the
indicator: “Proportion of women who received intermittent preventive treatment for malaria during their
last pregnancy” and Table 5 will not be needed. This also brought up an issue to be discussed in the
MICS interviewer training—if more than several medications are reported to have been taken, there needs
to be some way to triage or group the types so that the interviewer knows the most critical are the anti-
malaria related drugs.
Possible IRS questions from the Zimbabwe DHS: “During the past 12 months, has anyone sprayed the interior
walls of your dwelling against mosquitoes? If YES: How many months ago was the house sprayed?”; “Who sprayed
DRAFT DRAFT DRAFT
MIS Manual Issues
Fred Arnold asked if the DHS anemia manual should be referred to or included in MIS package—as well
as the blood collection manual for parasite prevalence. He explained that the anemia manual will be
revised and available relatively soon from DHS. The parasite prevalence testing manual from DHS will
also need to be revised and updated with Rapid Diagnostic Tests (RDTs) information before it is included
in the MIS.9 Rick Steketee offered to review and revise the parasite prevalence testing manual with
colleagues at the CDC and will provide a draft for the group to review in the next 4-6 weeks. If both
manuals are used in the MIS package, they should be presented together within the package due to the
order of operations/testing. It was decided that once both manuals are included in the package, there will
be an explanation of how to provide the two types of testing together.
Guidelines for Core RBM Indicators
Some key indicator issues were addressed for the revision of the “Guidelines for Core Population
Coverage Indicators for Roll Back Malaria: To be obtained from Household Surveys”. The IPT indicator
should be changed—the core indicator should read as: Proportion of women who received intermittent
preventive treatment for malaria according to national policy, during their last pregnancy. A secondary
indicator to this should read: Proportion of women who received any anti-malarial during their last
pregnancy. The definition will include, all women with a live birth in the last 2 years who took at least
two doses of SP/Fansidar (or anti-malarial or according to national policy, to capture ACT, as well;
however this may also include Chloroquine, but that can not be prevented) from ANC or other location.
The RBM prompt and effective treatment indicator for children under five needs to include the definition
of anti-malarial treatment as: any anti-malarial medication or anti-malarial medication according to the
national policy guidelines. The MIS can measure both, but local programs will need to advise on what is
recommended in the country for treatment. The effective issue is too complicated to sort out due to
different drugs that are used and available in country (some Chloroquine resistant countries are still using
IV. Plan for Dissemination of MIS Package and Implementation of First MIS in the Field
Bernard Nahlen, WHO/RBM
John Miller, WHO/RBM
Bernard Nahlen explained that those in the field have been asking for the MIS and it would be best for
RBM to provide the core sections very soon and then map out a time frame for the other sections that
might take longer to finalize. Below are the final issues related to dissemination of the MIS.
The package should be available on as many websites as possible (however to make updating the package
easier, put the documents on the RBM website only and have links on partner websites). There should
also be CD and hard copy versions as well.
Translation to French and other languages should be planned. MEASURE Evaluation through ORC
Macro can provide translation services. French is the current priority and then Spanish and possibly
Portuguese at a later date. Erin Eckert will check on cost and time for.
This manual is not available electronically. Please contact firstname.lastname@example.org if you would like a
copy of the 2001 DHS version.
DRAFT DRAFT DRAFT
Use of PDAs should be encouraged mainly for sampling and mapping however, more discussion needs to
take place for the use of PDAs in data collection. Alan Hightower and Rick Steketee of CDC are very
interested to work with the RBM MERG Survey Task Force to integrate PDA use with the MIS. Rick
explained that he has three to four programmers who are available to program PDAs for the MIS. The
sampling guidelines and data collection tool could be revised for use with PDAs by the CDC. It would
also be a good opportunity to test the MIS using the PDA once a country decides to do a national MIS;
additionally, testing could also take place at the district level to get a different perspective. Although,
using the PDAs have implications for the training curricula and most of the manuals would have to be
adapted and a full field test would need to be implemented. Steketee and his team would be interested in
taking the tools into the field and developing a training manual/curriculum in collaboration with RBM.
Other issues that need to be addressed if the PDAs are used: battery length and strength for the PDAs. If
PDAs are ultimately used with the MIS, it should be reiterated to the MoH and other national level staff
who usually work on surveys that their expertise will still be needed and their job responsibilities or
capacity will only change. Steketee has costing examples for using the PDAs from the Measles National
Survey that took place in Togo where CDC used PDAs. He will provide this information to the Survey
Task Force in the next few weeks. Bernhard Nahlen suggested that it would be helpful to use PDAs
during the first or second countries that use the MIS so as to provide a comparison.
Revision, Editing, Publishing Issues
The MIS Package will undergo final revisions and updates for a March 1, 2005 (or soon after) release of
the first version (through MEASURE/ORC Macro).10 Joint logo and publication issues will need to be
reviewed by Bernard Nahlen and Tessa Wardlaw at WHO and UNICEF and they will follow up with the
group in the next few weeks. Rich Steketee said that logos and publication restrictions will not be a
problem for CDC. The MIS package should use British English and the document will be copy edited as
well. There will be three formats available: a hardcopy binder, a CD and posted to the internet (in Word
and PDF; initial dissemination will be through the internet). All the Task Force members will assist in
different sections of the MIS package (see responsibilities matrix below) and Kate Macintyre will have a
PhD student at Tulane University help compile the package for publication.
Technical Assistance (TA) Issues
RBM needs to link TA for the MIS and other malaria related M&E in countries to the Ministry of Health
(MoH) and foster partnerships among MoH and TA providers, especially with the Global Fund for AIDS,
TB and Malaria (GFATM) principle recipients (PR).11 The initial sites for the pilot tests of the MIS could
include local partners/institutions that might be able to then provide TA to other countries—this could be
a capacity building component as the first few surveys are rolled out. Also, other country representatives
(from MOH, Statistics Bureau etc.) could be invited to participate in an MIS in a different country to
receive initial training and then return to their countries to administer the survey. Tessa Wardlaw and
Bernhard Nahlen will talk with partner agencies to assess who might be able to provide TA for the MIS
Plans for Implementation of MIS/Pilot
Liberia might be a very good candidate for the first MIS—they are conducting the Malaria Indicator
Survey (MIS). The end of August and September 2005 might be a good time to plan for the survey.
Liberia also has resources from the GFATM in their monitoring and evaluation (M&E) plan. There still
needs to be another meeting with Liberia and the key partners to go through the details and outline
funding, however some logistical groundwork has already been completed and resources are available, so
Please see the responsibilities matrix at the end of this document.
GFATM information, please visit: http://www.theglobalfund.org/en/
DRAFT DRAFT DRAFT
it should be kept in mind as possibly one of the first countries to use the MIS. If the package is made
available by March 1, 2005 and TA to be provided is agreed upon, then it seems like Liberia might be a
good option. Nathan Bakyaita at the WHO Regional Office for Africa (AFRO) will follow up regarding
Liberia and possible PDA use for the survey. Fred Arnold reminded the group that if a survey is to take
place in August or September of this year, then major planning will need to start very soon. Bernard
Nahlen also explained that WHO and GFATM and possibly other partners would assist with the field test
as well as members of the MERG.
Erin Eckert mentioned that USAID would like to assist in funding an MIS in another country—
presumably a country that does not have a MICS or DHS and needs outside funding, most likely in Africa
or possibly somewhere else. The funding from USAID would be “Core Funding” or from headquarters,
not from a specific country, however the country should be one where USAID is present. There is also a
certain amount available for printing and other work on the total MIS package.
Priority countries for RBM might include: Burundi, Benin, and Burkina Faso or in Asia, possibly Laos.
The group should also keep in mind that Senegal, Zambia, Ghana, Tanzania, Malawi, Nigeria, Mali,
Eritrea, Ethiopia and Benin all have had or are planning a DHS and the recent DHS has at least, the partial
malaria module included. UNICEF, DHS and RBM will talk and compile a country list for Sub-Saharan
Africa (SSA), including sufficient malaria endemnicity information to make a decision on priority
countries in the next few weeks. Eventually, the information in the MIS should be incorporated into the
GFATM and partners M&E Toolkit.12
“Lean” Malaria Module Update
There was some misunderstanding about how a “Lean” or scaled down Malaria module would be
presented in the “Guidelines for Core Population Coverage Indicators for Roll Back Malaria: To be
obtained from Household Surveys”. The group discussed how it should be presented in the next version
of the “Guidelines”. Many in the group agreed that what is needed is the leanest module as possible,
which should include questions on children under five sleeping under bednets, treatment of fever in
children and household availability of bednets (not a net roster, as this can be intimidating and unlikely to
be added on to surveys because it is so detailed)—the idea is to increase the likely-hood that these
questions will be added to other questionnaires. Nathan Bakyaita added that Uganda is trying to select
questions from the core guidelines and they are having difficulties choosing the questions to include.
Other countries may be having the same problem and more guidance in choosing the minimum package
of questions to add on would be helpful. It was decided that the revised “Guidelines” should include a
narrative to describe what one should consider to get the information needed using the minimum amount
of questions. The revised MIS and MICS will also be included as an addendum (Tessa Wardlaw will
send the revised MICS and Fred Arnold will send the revised MIS to Erin Eckert and Thom Eisele). Erin
Eckert and Thom Eisele will work on the “Lean” module and by the end of January or February 2005.
V. Next Steps
• Please see complete responsibilities matrix below.
• The format will be distributed as a hardcopy binder, CD and it will be posted to the internet (in
Word and PDF; initial dissemination will be through the internet.
• The MIS Package will undergo final revisions and updates for a March 1, 2005 (or soon after)
release of the first version (through MEASURE/ORC Macro).
To download or review the GFATM and Partners M&E Toolkit, please visit:
DRAFT DRAFT DRAFT
• Nahlen and Wardlaw will follow up on logos and approval of the package and get back to the
group in the next few weeks.
• Tessa Wardlaw and Bernhard Nahlen will talk with partner agencies about providing TA for the
MIS package at the country level.
• Nathan Bakyaita at AFRO will follow up/report on using the MIS in Liberia.
• UNICEF, DHS and WHO/RBM will talk and compile a list in the next few weeks of Sub-Saharan
African (SSA) countries, including malaria endemnicity information to make a decision on
priority countries for the MIS.
• Erin Eckert will check on costs and time frame for translation to French and Spanish.
• Rick Steketee, CDC will provide information to the Survey Task Force in the next few weeks on
costs of using the PDA with the MIS
Revision of the “Guidelines”
• Thom Eisele and Ani Hyslop have suggested changes to the core guidelines and Task Force
members are encouraged to send additional feedback as soon as possible. Thom will make the
• Erin Eckert and Thom Eisele will work on revising the “Lean Malaria Module” that will be
included in the “Guidelines” and send it around to make sure it is appropriate by the end of
January/beginning of February 2005
• Tessa Wardlaw to send revised MICS (field testing MICS in the next month) to Erin and Thom.
• Fred Arnold to send revised MIS to Erin and Thom.
• Facility Surveys to be discussed during the next MERG meeting in Cairo, Egypt 4-5 May 2005.
Possibly the Task Force could meet the day before or day after for side meeting.
• If there are questions about calculating indicators or feedback on the MICS, please contact Pat
David as soon as possible (email@example.com).
• Survey Task Force Meeting: TBD
• RBM MERG Meeting to be held in Cairo, Egypt 4-5 May 2005. Information will be sent in the
next several weeks.
DRAFT DRAFT DRAFT
VI. Training/Capacity Building Side Meeting
Bernard Nahlen, RBM/WHO
Erin Eckert, MEASURE Evaluation/ORC Macro
John Miller, RBM/WHO
Nathan Bakyaita, MoH Uganda/WHO AFRO
Mounkaila Abdou, MEASURE Evaluation/JSI
Maggie Janes, MEASURE Evaluation/ORC Macro
A small group of MERG members met for a brief meeting on training and capacity building issues to
layout next steps and plans in this area for RBM M&E. Erin Eckert outlined some of the possibilities
that MEASURE Evaluation could assist RBM with, which included developing a Malaria M&E module
that could be used in the MEASURE Evaluation Population, Health and Nutrition (PHN) courses and
used for RBM purposes.13 A stand alone course of one week could be developed for M&E of Malaria
programs for program managers, M&E focal points and district health officers. Additional ideas
proposed included providing country by country specific workshops for national programs, follow-on
workshops after large international conferences and/or one day workshops in select locations.
Bernard Nahlen explained that working initially with the Malaria M&E focal points would be the best
plan. It was agreed that the next steps should follow:
1. Anglophone Africa: a free standing short course on M&E of Malaria programs with M&E
country level focal points, including a strong follow up component (TA, listserv, workshops etc.);
2. Work with Universities/Institutions to develop centers for excellence in M&E
a. There is already some interest with a partner in Sudan (WHO Regional Office for the
Eastern Mediterranean [EMRO])14
b. Dr. Seydou Doumbia, who attended the November 2004 RBM MERG meeting
representing the Malaria Research and Training Center, and Department of Public Health,
Faculty of Medicine, Pharmacy and Dentistry, University of Bamako, Mali, might also be
a contact for collaboration/capacity building.
c. Centre d’Etudes Supérieures en Gestion (CESAG) in Dakar, Senegal (who has
worked with MEASURE Evaluation and other organizations) as a possibility.
d. Discuss two to four regional centers in Africa to build capacity in Malaria M&E and to
• Two-three page description of lessons learned, collaborative management experiences, workshop
follow up activities of MEASURE Evaluation’s work with CESAG in Dakar, Senegal.
• Mounkaila Abdou will send information on CESAG, the most recent PHN training report (from
the August 2004 workshop), training materials and manual to John Miller, RBM/WHO.
Prepare for the next RBM MERG meeting, May 2005
• MEASURE Evaluation to present training and capacity building plan, including possible
timeline/dates with RBM MERG
• Present possible partners: Sudan (EMRO contact); University of Pretoria, South Africa;
Eastern Africa Partner (Nathan will follow up); CESAG in Senegal or Bamako, Mali;
• General outline for the short course on M&E of Malaria programs;
• WHO to identify M&E focal points in each country and/or region.
For more information on the MEASURE Evaluation PHN curriculum and training workshops, visit:
For more information, please visit: http://www.emro.who.int/index.asp
DRAFT DRAFT DRAFT
MIS Component Responsible Time Frame Issues
Overview/Intro document John 14-Jan Preface, acknowledgements, cover design,
monitoring the MDGs, partnerships MOH
and Bur Stats
MIS Rationale Alex, (Thom) 14-Jan
Guidelines for Core Population Indicators for Roll Back Ani, Thom, (Erin) For next revision Erin and Thom to work on "lean" module
Malaria: to be obtained from household surveys included in the guidelines by end of Jan. 05
Household and Women’s Questionnaire Ani, Alex, (Thom) 14
Selected data tabulation plan Ani, (Alex), Thom 14 Focus on core indicators
Sampling Manual Alex, Thom, Allan 21-Jan Outline steps for sampling frame
Hightower developed with sampling stats person and
person with local malaria knowledge, pull
out controversial issues and complete
Supervisor’s Manual Done, Kate 14-Jan Fred to send Kate information on
GPS/geocoding to include as reference.
Interviewer’s Manual Erin and Thom 21-Jan In reference to the questionnaire
Training Manual Done, Kate 14-Jan
Household Listing Manual Done, review by Kate 14-Jan
Anemia Testing Fred (DHS), Jasbir Sanga 6 weeks (2/28)
Parasite Testing CDC (Rick) 6 weeks (2/28) To be developed/ follow up on RDTs
meeting, Bernhard to send rapid testing
report for reference.
GPS Manual John 14-Jan geocoding is important (add to
PDA Manual for 1) field data collection and 2) sampling Rick and team For second version of
the package, addendum
Costing issues Tessa (using MICS, DHS and 14-Jan needs modifications/send Liberia
Liberia example) example/DHS example/incorporating
PDAs too (Rick/Alan Hightower?)
DRAFT DRAFT DRAFT
Data management and processing John add to introduction general statements
about the capacity for data management
within Statistics Departments, partner
agencies, encouraging public access and
use of data sets and results. Compile these
datasets within RBM. Also Rick/Alan?
Institutional Review/Logos Tessa and Bernhard Jan
Copy edited; UK spelling; Ring binder and
CD-ROM, one website with links on
Format all By March 1, 2005 partner websites
DRAFT DRAFT DRAFT
LIST OF PARTICIPANTS
WORLD HEALTH ORGANIZATION
Dr Bernard Nahlen, Coordinator, M&E, WHO/HQ – Geneva
Mr John MILLER, Technical Officer, RBM/MME, WHO/HQ – Geneva
Dr Nathan BAKYAITA, Malaria Control Programme, MOH/Uganda /WHO AFRO
Dr Tessa WARDLAW, Senior Programme Officer, Statistics; Division of Policy and Planning, USA
Dr Mounkaila ABDOU, MEASURE Evaluation, JSI, USA
Dr Fred ARNOLD, ORC Macro, USA
Dr Patricia DAVID, JSI, USA
Dr Erin ECKERT, Principal Investigator, MEASURE Evaluation, ORC Macro, USA
Dr Thom EISELE, Tulane University, Department of International Health and Development, USA
Dr Ani Hyslop, MEASURE Evaluation, ORC Macro, USA
Ms. Maggie JANES, MEASURE Evaluation, ORC Macro, USA
Dr Kate MACINTYRE, Tulane University/MEASURE Evaluation, USA
Dr Alexander ROWE, Centers for Diseases Control (CDC), USA
Dr Richard STEKETEE, Chief, Malaria Epidemiology Branch, Division of Parasitic Diseases, Centers for
Diseases Control (CDC), USA